Literature DB >> 2778033

Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans.

D K Snyder1, D R Clemmons, L E Underwood.   

Abstract

To determine if diet composition influences responses to GH, we fed 11 obese women diets containing 12 Cal/kg ideal BW (IBW) for 2 5-week study intervals. Nonprotein calories were supplied to 6 subjects as 72% carbohydrate (high carbohydrate diet), and 5 subjects received 80% of their nonprotein calories as lipid (high lipid diet). Protein intake was constant (1.0 g/kg IBW) in both groups. During 1 study interval we gave injections of GH (0.1 mg/kg IBW) every other day for 3 weeks (weeks 2-4), and in the other interval injections of vehicle were given. Subjects ingesting the high carbohydrate diet excreted significantly less urinary nitrogen [660.2 +/- 124.1 mmol/day (mean +/- SD)] than those who received high lipid (794.2 +/- 198.5 mmol/day; P less than 0.001), and GH injections reduced nitrogen excretion in the high carbohydrate subjects (532.8 +/- 123.8 mmol/day), but not in the high lipid subjects (743.7 +/- 126.6 mmol/day). The subjects receiving the high carbohydrate diet had a significant increase in serum insulin-like growth factor-I (IGF-I; from 36.2 +/- 9.7 to 55.9 +/- 6.6 nmol/L) and urinary C-peptide excretion (from 43.9 +/- 25.6 to 60.8 +/- 29.4 nmol/day) in response to GH. The IGF-I response attenuated slowly over the 3-week treatment interval. On the other hand, the high lipid group had lesser increases in IGF-I (from 31.0 +/- 6.5 to 41.7 +/- 8.8 nmol/L) and C-peptide excretion (from 24.3 +/- 28.9 to 29.8 +/- 32.8 nmol/day), and IGF-I concentrations declined to control values after only 5 days of GH injection. We believe that this initial IGF-I response was due to an antecedent 35-Cal balanced diet. The mean increment in serum FFA 4 h after GH injection was significantly less in subjects fed the high lipid diet (0.53 +/- 0.40 meq/L) than in those fed the high carbohydrate diet (0.83 +/- 0.43 meq/L). GH injections produced more body fat loss than injections of vehicle whether expressed as percent body fat lost (GH, 3.7 +/- 1.0%; vehicle, 2.8 +/- 0.7%, P less than 0.05) or as the fraction of weight lost as fat (fat loss/weight loss; GH, 0.81 +/- 0.13; vehicle, 0.64 +/- 0.08; P less than 0.005). There was an inverse correlation between the percentage of body fat lost and mean urinary C-peptide excretion during GH injections (r = -0.70; P less than 0.05), suggesting that stimulation of insulin secretion by GH might antagonize the tendency of GH to promote fat loss.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2778033     DOI: 10.1210/jcem-69-4-745

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Contribution of hGH20K variant to blood hGH response in sauna and exercise.

Authors:  S Doré; G R Brisson; A Fournier; R Montpetit; H Perrault; D Boisvert
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

2.  The influence of chronic administration of the serotonin agonist dexfenfluramine on responsiveness to corticotropin releasing hormone and growth hormone-releasing hormone in moderately obese people.

Authors:  M L Drent; H J Adèr; E A van der Veen
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

Review 3.  Nutrition and the insulin-like growth factor system.

Authors:  C F Estívariz; T R Ziegler
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

4.  Perioperative growth hormone treatment and functional outcome after major abdominal surgery: a randomized, double-blind, controlled study.

Authors:  P Kissmeyer-Nielsen; M B Jensen; S Laurberg
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

5.  The influence of fast and vegetarian diet on parameters of nutritional status in patients with rheumatoid arthritis.

Authors:  M A Haugen; J Kjeldsen-Kragh; N Skakkebaek; S Landaas; O Sjaastad; P Movinkel; O Førre
Journal:  Clin Rheumatol       Date:  1993-03       Impact factor: 2.980

6.  Effects of exercise during normoxia and hypoxia on the growth hormone-insulin-like growth factor I axis.

Authors:  W Schmidt; S Doré; A Hilgendorf; S Strauch; R Gareau; G R Brisson
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

7.  Effects of recombinant human growth hormone in patients with severe sepsis.

Authors:  H J Voerman; R J van Schijndel; A B Groeneveld; H de Boer; J P Nauta; E A van der Veen; L G Thijs
Journal:  Ann Surg       Date:  1992-12       Impact factor: 12.969

Review 8.  Growth hormone and exercise tolerance in patients with cystic fibrosis.

Authors:  Matthias Hütler; Ralph Beneke
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

9.  Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.

Authors:  S R Kupfer; L E Underwood; R C Baxter; D R Clemmons
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

10.  Exogenous recombinant human growth hormone effects during suboptimal energy and zinc intake.

Authors:  Russell Rising; Julio F Scaglia; Conrad Cole; Rozalia Tverskaya; Debora Duro; Fima Lifshitz
Journal:  Nutr Metab (Lond)       Date:  2005-04-07       Impact factor: 4.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.